Volume 24, Number 11—November 2018
Dispatch
Rickettsia japonica Infections in Humans, Zhejiang Province, China, 2015
On This Page
Qunying Lu
, Jianping Yu, Liqun Yu, Yanjun Zhang, Yitao Chen, Meiai Lin, and Xiaofei Fang
, Jianping Yu, Liqun Yu, Yanjun Zhang, Yitao Chen, Meiai Lin, and Xiaofei FangAbstract
We investigated 16 Japanese spotted fever cases that occurred in southeastern China during September–October 2015. Patients had fever, rash, eschar, and lymphadenopathy. We confirmed 9 diagnoses and obtained 2 isolates with high identity to Rickettsia japonica strain YH. R. japonicainfection should be considered for febrile patients in China.
Rickettsia japonica is a member of the spotted fever group rickettsiae (SFGR) that causes tickborne Japanese spotted fever (JSF). First reported in Japan’s Tokushima Prefecture in 1984 (1,2), JSF has been recognized in multiple countries of Asia, including Japan, South Korea, the Philippines, and Thailand (3–5). In China, 4 species of SFGR have been reported to cause human infection: R. heilongjiangensis, R. sibirica subspecies sibirica BJ-90, Candidatus R. tarasevichiae, and R. raoultii (6). In this report, we investigated the causative agent of 16 JSF cases that occurred in southeastern China in late 2015.
The ethics committee of the Zhejiang Province Center for Disease Control and Prevention, Hangzhou, China, approved this research. During September–October 2015, a total of 16 febrile patients were hospitalized at Linan First People’s Hospital (Linan, China). All these patients lived in the Xitianmu Mountain area of Linan in Zhejiang Province. Besides fever (38.8°C–40.3°C), clinical signs of disease in these patients included rashes on the trunk and limbs (15/16) and an eschar (11/16) (Table). In those with eschar, lymphadenopathy was found at the site of the draining lymph node (6/11). Five patients had rash and no eschar. Laboratory results revealed that all patients’ leukocyte levels were within reference ranges, but a high percentage of neutrophils (12/16 patients) and minor hepatic transaminase elevation (11/16 patients) were also observed. All 16 patients were treated with doxycycline or azithromycin and were cured, and no patient experienced severe illness.
With patient consent, we collected acute-phase (n = 16) and convalescent-phase (n = 14) whole blood specimens and sent them to Zhejiang Province Center for Disease Control and Prevention for laboratory confirmation of Rickettsia infection. We extracted DNA from acute-phase blood specimens by using the DNeasy Blood & Tissue Kit (QIAGEN, Hilden, Germany). We used nested PCR to amplify the partial groEL genes of SFGR, typhus group rickettsiae, and Orientia tsutsugamushi bacteria (Technical Appendix). The targeted fragments (217 bp) were present in the blood specimens from 9 patients (Table). We sequenced these fragments and analyzed them using BLAST (http://www.ncbi.nlm.nih.gov/BLAST), and all had 100% identity to R. japonica YH prototype strain (GenBank accession no. NC016050) (7,8). All specimens were negative for typhus group rickettsiae and O. tsutsugamushirickettsia DNA by PCR.
We also inoculated 200 μL of acute-phase blood specimens onto HL60 and DH82 cells in 25-mL flasks and cultured at 37°C. Cytopathic effect was not observed with inoculated HL60 cells, but inoculated DH82 cells exfoliated completely by 4 weeks of culture. We also performed indirect immunofluorescence assays (IFAs) every 2 days to access SFGR growth (Technical Appendix). Two of the inoculated cultures exhibited bright fluorescent apple-green, rod-shaped particles (Table) after 3 weeks of culture, confirming SFGR infection for 2 patients. We then extracted DNA from the 2 SFGR-positive cultures (LA4/2015 and LA16/2015) and amplified and sequenced a 2,493-bp fragment containing the full-length sequences of SFGR groES and groEL (GenBank accession nos. KY073364–5) and a 609-bp fragment containing the partial rickettsial ompA gene sequence (GenBank accession nos. KY347792–3; Technical Appendix Table). These sequences were found to be 100% identical to the corresponding sequences of R. japonica YH.
We used IFAs with bacterial substrate antigens R. japonica (HL-60 cells infected with LA4/2015) and R. rickettsii (FOCUS Diagnostics Inc., Cyprus, CA, USA) to test patients for specific antibodies, and in all 16 patient serum samples, we detected SFGR IgG. All paired serum samples (n = 14) showed a >4-fold increase in titer against SFGR (Table). The 2 patients we did not receive convalescent-phase serum specimens from were positive for R. japonica by PCR.
All serum specimens were negative for O. tsutsugamushi IgG. Some convalescent-phase serum specimens had low-titer reactions to R. typhi bacterial antigen.
The 4 SFGR species R. japonica, R. heilongjiangensis, R. rhipicephali, and R. massiliae have been identified in Haemaphysalis longicornis and Rhipicephalus haemaphysaloides ticks in Zhejiang Province (9–11), indicating a potential for these species to infect humans in China. In our research, we determined the etiologic agent of 16 JSF cases and isolated 2 R. japonica rickettsiae. The prototype strain R. japonica YH was isolated in Japan in 1985 (1). After ≈30 years, only a few R. japonica isolates have been isolated from patients in China: 2 from our research and 1 from Li et al. (12). Our findings indicate that the full-length groES and groEL genes and the partial ompA gene sequences were 100% identical to R. japonica YH, suggesting that the R. japonica genome has been relatively conserved. Nine patients had clinically confirmed JSF, displaying fever, rash, eschar, and lymphadenopathy; these signs and symptoms were similar to those seen in JSF patients in Japan (13).
Of the vectorborne rickettsial diseases in China, human scrub typhus and murine typhus frequently occur in Zhejiang Province, and spotted fever group rickettsiosis probably occurs but has gone relatively unnoticed. Because the clinical symptoms of spotted fever and scrub typhus are similar, some SFGR infections have likely been diagnosed as scrub typhus. We found that the blood specimens of 7 febrile patients were negative for the targeted PCR fragments but showed a >4-fold increase in antibody titer to SFGR. Although these results suggest SFGR infection, we cannot conclude these 7 patients were infected with R. japonica.
In summary, R. japonica infections occur in Zhejiang Province, China. These infections are likely more broadly distributed throughout the mainland areas than had been previously realized. Improvements in JSF clinical diagnosis and human epidemiologic surveillance are urgently needed in China.
Dr. Lu is a principal investigator at the Zhejiang Province Center for Disease Control and Prevention, Hangzhou, China. Her research interests include microbiology, epidemiology, and the ecology of tickborne diseases.
Acknowledgment
We thank our colleagues in the Linan First People’s Hospital, Zhejiang Province, Linan, China, for their assistance in specimen collection.
References
- Mahara F. Three Weil-Felix reaction OX2 positive cases with skin eruptions and high fever [in Japanese]. J Anan Med Assoc. 1984;68:4–7.
- Camer GA, Alejandria M, Amor M, Satoh H, Muramatsu Y, Ueno H, et al. Detection of antibodies against spotted fever group Rickettsia (SFGR), typhus group Rickettsia (TGR), and Coxiella burnetii in human febrile patients in the Philippines. Jpn J Infect Dis. 2003;56:26–8.PubMed
- Meng Z, Jiang LP, Lu QY, Cheng SY, Ye JL, Zhan L. [Detection of co-infection with Lyme spirochetes and Spotted fever group rickettsiae in a group of Haemaphysalis longicornis]. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29:1217–20.PubMed
- Cheng SY, Zheng SQ, Meng Z, Ye XD, Jiang LP, Wang ZQ, et al. Analysis of DNA sequences of spotted fever group Rickettsia detected from ticks in Zhejiang Province [in Chinese]. Dis Surveil. 2010;25:466–8.
- Li J, Hu W, Wu T, Li HB, Hu W, Sun Y, et al. Japanese spotted fever endemic in East China, 2013. Emerg Infect Dis. 2018;24. DOI
Table
Cite This ArticleOriginal Publication Date: 9/24/2018
No hay comentarios:
Publicar un comentario